1001 - Document - Cover Page link:presentationLink link:definitionLink link:calculationLink 1002 - Statement - Condensed Balance Sheet link:presentationLink link:definitionLink link:calculationLink 1003 - Statement - Condensed Balance Sheet (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1004 - Statement - Condensed Statement of Operations link:presentationLink link:definitionLink link:calculationLink 1005 - Statement - Condensed Statement of Changes in Shareholders' Deficit link:presentationLink link:definitionLink link:calculationLink 1006 - Statement - Condensed Statement of Changes in Shareholders' Deficit (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1007 - Statement - Condensed Statement of Cash Flows link:presentationLink link:definitionLink link:calculationLink 1008 - Disclosure - Description of Organization and Business Operations link:presentationLink link:definitionLink link:calculationLink 1009 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 1010 - Disclosure - Initial Public Offering link:presentationLink link:definitionLink link:calculationLink 1011 - Disclosure - Proposed Public Offering link:presentationLink link:definitionLink link:calculationLink 1012 - Disclosure - Accounts payable and accrued expenses link:presentationLink link:definitionLink link:calculationLink 1013 - Disclosure - Income taxes link:presentationLink link:definitionLink link:calculationLink 1014 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 1015 - Disclosure - Commitments & Contingencies link:presentationLink link:definitionLink link:calculationLink 1016 - Disclosure - Shareholders' Deficit link:presentationLink link:definitionLink link:calculationLink 1017 - Disclosure - Redeemable Convertible Preferred Stock link:presentationLink link:definitionLink link:calculationLink 1018 - Disclosure - Segment Information link:presentationLink link:definitionLink link:calculationLink 1019 - Disclosure - Fair Value Measurements link:presentationLink link:definitionLink link:calculationLink 1020 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 1021 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 1022 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 1023 - Disclosure - Accounts payable and accrued expenses (Tables) link:presentationLink link:definitionLink link:calculationLink 1024 - Disclosure - Income taxes (Tables) link:presentationLink link:definitionLink link:calculationLink 1025 - Disclosure - Related party transactions (Tables) link:presentationLink link:definitionLink link:calculationLink 1026 - Disclosure - Shareholders' Deficit (Tables) link:presentationLink link:definitionLink link:calculationLink 1027 - Disclosure - Segment Information (Tables) link:presentationLink link:definitionLink link:calculationLink 1028 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:definitionLink link:calculationLink 1029 - Disclosure - Subsequent events (Tables) link:presentationLink link:definitionLink link:calculationLink 1030 - Disclosure - Description of Organization and Business Operations - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 1031 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 1032 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Summary of Basic and Diluted Net Income (Loss) Per Ordinary Share (Details) link:presentationLink link:definitionLink link:calculationLink 1033 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Summary of Possible Redemption Reflected in the Balance Sheet (Details) link:presentationLink link:definitionLink link:calculationLink 1034 - Disclosure - Initial Public Offering - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 1035 - Disclosure - Proposed Public Offering - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 1036 - Disclosure - Accounts payable and accrued expenses - Summary of the components of accounts payable and accrued expenses (Details) link:presentationLink link:definitionLink link:calculationLink 1037 - Disclosure - Income taxes - Schedule of reconciles the UK statutory income tax rate (Details) link:presentationLink link:definitionLink link:calculationLink 1038 - Disclosure - Income taxes - Schedule of The significant components of the Company's net deferred income taxes (Details) link:presentationLink link:definitionLink link:calculationLink 1039 - Disclosure - Income taxes - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 1040 - Disclosure - Related Party Transactions - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 1041 - Disclosure - Related party transactions - Schedule Of Amount Payable To Related Party (Details) link:presentationLink link:definitionLink link:calculationLink 1042 - Disclosure - Related party transactions - Schedule Of Allocations Are Reflected Statements Of Operations (Details) link:presentationLink link:definitionLink link:calculationLink 1043 - Disclosure - Commitments & Contingencies - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 1044 - Disclosure - Shareholders' Deficit - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 1045 - Disclosure - Shareholders' Deficit - Schedule Of Issuance Of Common Shares For Purpose Of Calculating Loss Per Shares (Details) link:presentationLink link:definitionLink link:calculationLink 1046 - Disclosure - Redeemable Convertible Preferred Stock - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1047 - Disclosure - Segment Information - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 1048 - Disclosure - Segment Information - Summary of Evaluating the Company's Performance and Making Key Decisions Regarding Resource Allocation (Details) link:presentationLink link:definitionLink link:calculationLink 1049 - Disclosure - Segment Information - Summary of expense categories regularly reviewed by the CODM (Details) link:presentationLink link:definitionLink link:calculationLink 1050 - Disclosure - Fair Value Measurements - Summary of Fair Value Hierarchy of the Valuation Techniques (Details) link:presentationLink link:definitionLink link:calculationLink 1051 - Disclosure - Subsequent Events - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 1052 - Disclosure - Subsequent events - Schedule Of Issuance Of Common Shares For Purpose Of Calculating Loss Per Shares (Details) link:presentationLink link:definitionLink link:calculationLink 1053 - Statement - Condensed Balance Sheet Alternate 1 link:presentationLink link:definitionLink link:calculationLink Cover [Abstract] Document Information [Table] Document Information, Document [Axis] Document [Domain] Business Contact [Member] Document Information [Line Items] Document Type Amendment Flag Entity Tax Identification Number Entity Registrant Name Entity Central Index Key Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Ex Transition Period Inception Date Inception date. Entity Primary SIC Number Contact Personnel Name Class of Stock [Axis] Class of Stock [Domain] Statement of Financial Position [Abstract] Statement [Table] Common Class A [Member] Common Class A [Member] Class A ordinary shares [Member] Class A Ordinary Shares [Member] Class A subject to redemption [Member] Common Class B [Member] Common Class B [Member] Class B Ordinary Shares [Member] Statement [Line Items] Assets [Abstract] ASSETS Deferred Costs, Noncurrent Deferred offering costs Assets Total Assets Assets, Current [Abstract] Current assets Cash Cash Cash Prepaid Clinical Trial Costs Prepaid clinical trial costs Prepaid clinical trial costs. Prepaid Taxes Prepaid taxes Assets, Current Total current assets Prepaid Expense, Current Prepaid expenses Assets, Noncurrent [Abstract] Noncurrent assets Deferred Offering Costs Deferred offering costs Assets, Noncurrent Total noncurrent assets Deposits Assets, Noncurrent Deposits Prepaid Expense, Noncurrent Long-term prepaid expenses Debt Securities, Available-for-Sale, Noncurrent Marketable securities held in Trust Account Liabilities and Equity [Abstract] LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS' DEFICIT Liabilities, Current [Abstract] Current liabilities: Accrued Offering Costs Current Accrued offering costs Accrued offering costs. Accrued Liabilities, Current Accrued expenses Accounts Payable and Accrued Liabilities, Current Accounts payable and accrued expenses Total accounts payable and accrued expenses Due To Parent Co Due to parent Co. Due to parent co. Liabilities, Current Total Current Liabilities Accounts Payable, Current Accounts payable Accounts payable Liabilities Total liabilities Deferred Underwriting Fee Payable Deferred underwriting fee payable Deferred Underwriting Fee Payable. Commitments and Contingencies Commitments and Contingencies Equity, Attributable to Parent [Abstract] Shareholders' Deficit Preferred Stock, Value, Issued Preference shares, $0.0001 par value, 1,000,000 shares authorized; none issued and outstanding Common Stock, Value, Issued Common Stock, Value, Issued Additional Paid in Capital Additional paid-in-capital Retained Earnings (Accumulated Deficit) Accumulated deficit Equity, Attributable to Parent Total Shareholders' Deficit Beginning balance, amount Ending balance, amount Liabilities and Equity TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS' DEFICIT Temporary Equity [Abstract] Mezzanine equity Temporary Equity, Carrying Amount, Attributable to Parent Series A redeemable convertible preferred stock, $0.000001 par value; 32,500,000 and none authorized, issued and outstanding as of June 30, 2026 and December 31, 2025 respectively Temporary Equity, Par Value Class A ordinary shares subject to possible redemption, 7,500,000 shares at a redemption value of $10.00 per share Class A ordinary shares subject to possible redemption, June 30, 2026 Legal Entity [Axis] Entity [Domain] OHB Pediatrics Ltd [Member] Common Stock [Member] Common Stock [Member] Series A Redeemable Preferred Stock [Member] Non Redeemable Class A Ordinary Shares [Member] Non-redeemable Class A ordinary shares [Member] Redeemable Class A Ordinary Shares [Member] Redeemable Class A ordinary shares [Member] Preferred Stock, Par or Stated Value Per Share Preferred stock, par or stated value per share Preferred Stock, Shares Authorized Preferred stock, shares authorized Preferred Stock, Shares Issued Preferred stock, shares issued Preferred Stock, Shares Outstanding Preferred stock, shares outstanding Common Stock, Par or Stated Value Per Share Common stock, par or stated value per share common stock, par or stated value per share Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued common stock, shares, issued Common stock, shares, issued Common Stock, Shares, Outstanding Common stock, shares, outstanding Common stock, shares, outstanding Temporary Equity, Par or Stated Value Per Share Temporary equity, par or stated value per share Temporary Equity, Shares Authorized Temporary equity, shares authorized Temporary Equity, Shares Issued Temporary equity, shares issued Temporary Equity, Shares Issued Temporary Equity, Shares Outstanding Class A ordinary shares subject to possible redemption Temporary Equity, Shares Outstanding Temporary Equity, Redemption Price Per Share Class A ordinary shares, redemption value Equity Components [Axis] Equity Component [Domain] Preferred Stock [Member] Income Statement [Abstract] Net Income (Loss) Attributable to Parent Net income (loss) Net income (loss) Net loss Allocation of net income (loss) Earnings Per Share, Basic Net income (loss) per ordinary share, basic Earnings Per Share, Diluted Net income (loss) per ordinary share, diluted Weighted Average Number of Shares Outstanding, Basic Weighted average ordinary shares outstanding, basic Weighted-average ordinary shares outstanding Weighted Average Number of Shares Outstanding, Diluted Weighted average ordinary shares outstanding, diluted Operating Expenses [Abstract] General and Administrative Expense General, formation and administrative expenses General and administrative expense General and administrative expenses Total general and administrative costs Research and Development Expense Research and development Total research and development costs Operating Expenses Total operating expenses Operating Income (Loss) Loss from operations Nonoperating Income (Expense) [Abstract] Other income / (expense): Gain (Loss), Foreign Currency Transaction, before Tax Foreign currency gain (loss) Nonoperating Income (Expense) Total other income / (expense) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Loss from operations before taxes Income Tax Expense (Benefit) Income tax expense Effective tax rate - Values Interest and Other Income [Abstract] Other income: Investment Income, Interest Interest earned on marketable securities held in Trust Account Interest earned on marketable securities held in Trust Account Interest earned on marketable securities held in Trust Account Other Income Total other income Common Class A And B [Member] Class A and B ordinary shares [Member] Class A and B Non-Redeemable [Member] Statement of Stockholders' Equity [Abstract] Shares, Outstanding Beginning balance, shares Ending balance, shares Stock Issued During Period, Shares, New Issues Issuance of Class B ordinary shares to Sponsor, shares Issuance of shares, Shares Stock issued during period, shares, new issues Issuance Stock Issued During Period, Value, New Issues Issuance of Class B ordinary shares to Sponsor, amount Issuance of shares, Amount Issuance of shares Sale of Stock, Number of Shares Issued in Transaction Sale of Private Placement shares upon IPO, shares Sale of Stock, Number of Shares Issued in Transaction Proceeds from Issuance of Private Placement Sale of Private Placement shares upon IPO, amount Proceeds from the sale of Private Placement Shares Proceeds from issuance of private placement Temporary Equity, Carrying Amount, Period Increase (Decrease) Remeasurement of Class A ordinary shares subject to possible redemption to redemption value Remeasurement of carrying value to redemption value Additional Paid-in Capital [Member] Additional Paid-In Capital [Member] Retained Earnings [Member] Accumulated Deficit [Member] Series A Preferred Stock [Member] Sale of Stock [Axis] Sale of Stock [Domain] Preferred Share Offering Costs Offering costs Preferred share offering costs. Statement of Cash Flows [Abstract] Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Cash Flows from Operating Activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: General And Administrative Expenses Paid Through Issuance Of Class B Ordinary Shares To Sponsor General and administrative expenses paid through issuance of Class B ordinary shares to Sponsor General and administrative expenses paid through issuance of Class B ordinary shares to Sponsor. Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Changes in operating liabilities: Increase (Decrease) in Accrued Liabilities Accrued expenses Increase (Decrease) in Prepaid Expense Prepaid expenses Increase (Decrease) in Prepaid Taxes Prepaid taxes Increase (Decrease) in Deposit Assets Deposits Increase (Decrease) in Accounts Payable and Accrued Liabilities Accounts payable and accrued expenses Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Net cash used in operating activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Cash Flows from Financing Activities: Proceeds from Notes Payable Proceeds from Promissory Note - Sponsor Payments of Stock Issuance Costs Payment of offering costs Payments of stock issuance costs Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Net cash provided by financing activities Payments By Parent Company Payments by Parent Co. on behalf of OHB Pediatrics, Ltd. Payments by parent company. Payments of Financing Costs Payments of deferred offering costs Proceeds from Issuance of Common Stock Proceeds from issuance of Class B ordinary shares to Sponsor Proceeds from issuance of common stock Repayments of Notes Payable Repayment of Promissory Note - Sponsor Repayments of notes payable Proceeds from Issuance Initial Public Offering Proceeds received from Initial Public Offering of Public Shares, net of underwriting commissions Proceeds from issuance initial public offering Proceeds from Issuance of Redeemable Convertible Preferred Stock Proceeds received from issuance of Series A redeemable convertible preferred stock, net Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Net Change in Cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Cash – beginning of the period Cash – end of the period Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Supplemental disclosure of non-cash investing and financing activities: Deferred Offering Costs Included In Accrued Offering Costs Deferred offering costs included in accrued offering costs Deferred offering costs included in accrued offering costs. Non Cash General And Administrative Costs Paid By Sponsor General and administrative costs paid by Sponsor in exchange for issuance of Class B ordinary shares Non cash general and administrative costs paid by sponsor. Non Cash Issuance Of Shares Issuance of shares Non cash issuance of shares. Non Cash Deferred Underwriting Fee Payable Deferred underwriting fee payable Non cash deferred underwriting fee payable. Non Cash Recognition Deferred Offering Costs Non-cash recognition of deferred offering costs Non Cash Recognition Deferred Offering Costs Cash Provided by (Used in) Investing Activity, Continuing Operation [Abstract] Cash Flows from Investing Activities Payments to Acquire Investments to be Held in Decommissioning Trust Fund Cash deposited in Trust Account Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Net cash used in investing activities Organization, Consolidation and Presentation of Financial Statements [Abstract] Description of Organization and Business Operations [Table] Description of Organization and Business Operations [Line Items] Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] Description of Organization and Business Operations Accounting Policies [Abstract] Accounting Policies [Table] Accounting Policies [Line Items] Significant Accounting Policies [Text Block] Basis of Presentation and Summary of Significant Accounting Policies Initial Public Offering [Abstract] Initial Public Offering [Text Block] Initial Public Offering Initial public offering. Proposed Public Offering [Abstract] Proposed Public Offering [Text Block] Proposed Public Offering Proposed public offering text block. Accounts Payable and Accrued Liabilities, Current [Abstract] Accounts payable and accrued expenses [Table] Accounts payable and accrued expenses [Line Items] Accounts Payable and Accrued Liabilities Disclosure [Text Block] Accounts payable and accrued expenses Income Tax Disclosure [Abstract] Income taxes [Table] Income taxes [Line Items] Income Tax Disclosure [Text Block] Income taxes Related Party Transactions [Abstract] Related Party Transaction [Table] Related Party Transaction [Line Items] Related Party Transactions Disclosure [Text Block] Related Party Transactions Commitments and Contingencies Disclosure [Abstract] Loss Contingencies [Table] Loss Contingencies [Line Items] Commitments and Contingencies Disclosure [Text Block] Commitments & Contingencies Stockholders' Equity Note [Abstract] Stockholders Equity Note [Table] Stockholders Equity Note [Line Items] Equity [Text Block] Shareholders' Deficit Redeemable Convertible Preferred Stock [Abstract] Redeemable Convertible Preferred Stock [Table] Redeemable convertible preferred stock [Line Items] Redeemable Convertible Preferred Stock [Text Block] Redeemable convertible preferred stock Redeemable convertible preferred stock. Segment Reporting [Abstract] Segment Reporting [Table] Segment Reporting [Line Items] Segment Reporting [Line Items] Segment Reporting Disclosure [Text Block] Segment Information Fair Value Disclosures [Abstract] Fair Value Disclosures [Text Block] Subsequent Events [Abstract] Subsequent Event [Table] Subsequent Event [Line Items] Subsequent Events [Text Block] Subsequent Events Basis of Accounting, Policy [Policy Text Block] Basis of Presentation Emerging Growth Company [Policy Text Block] Emerging Growth Company Emerging growth company. Use of Estimates, Policy [Policy Text Block] Use of Estimates Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents Concentration Risk, Credit Risk, Policy [Policy Text Block] Concentration of Credit Risk Marketable Securities, Policy [Policy Text Block] Marketable Securities Held in Trust Account Fair Value of Financial Instruments, Policy [Policy Text Block] Fair Value of Financial Instruments Deferred Offering Costs [Policy Text Block] Deferred Offering Costs Deferred offering costs. Income Tax, Policy [Policy Text Block] Income Taxes Shares Subject to Mandatory Redemption, Changes in Redemption Value, Policy [Policy Text Block] Public Shares Subject to Possible Redemption Share-Based Payment Arrangement [Policy Text Block] Share-based Compensation New Accounting Pronouncements, Policy [Policy Text Block] Recent Accounting Pronouncements Derivatives, Policy [Policy Text Block] Derivative Financial Instruments In Process Research and Development, Policy [Policy Text Block] Research and development expenses and acquired in-process research & development ("IPR&D") Prepaid Clinical Trial Cost Policy [Text Block] Prepaid clinical trial costs Prepaid clinical trial cost policy. Foreign Currency Transactions and Translations Policy [Policy Text Block] Foreign currency translation Related Party Transactions Policy [Text Block] Related party transactions Related party transactions policy. Segment Reporting, Policy [Policy Text Block] Segment and geographic reporting Offering Cost Policy [Policy Text Block] Offering Costs Offering cost policy. Earnings Per Share, Policy [Policy Text Block] Net Income (Loss) Per Ordinary Share Earnings per share ("EPS") Deferred Charges, Policy [Policy Text Block] Deferred offering costs Preferred Stock, Redeemable [Policy Text Block] Redeemable convertible preferred stock Earnings Per Share [Abstract] Earnings Per Share [Abstract] Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Summary of basic and diluted net income (loss) per ordinary share Temporary Equity [Table Text Block] Summary of possible redemption reflected in the balance sheet Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Summary of the components of accounts payable and accrued expenses Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Schedule of reconciles the UK statutory income tax rate Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Schedule of The significant components of the Company's net deferred income taxes Schedule Of Amount Payable To Related Party [Table Text Block] Schedule of amount payable to related party Schedule of amount payable to related party. Schedule of allocations are reflected in statements of operations [Table Text Block] Schedule of allocations are reflected in statements of operations Schedule of allocations are reflected in statements of operations. Equity [Abstract] Stock, Class of Stock [Table] Class of Stock [Line Items] Schedule Of Issuance Of Common Shares For Purpose Of Calculating Loss Per Shares [Table Text Block] Schedule Of Issuance Of Common Shares For Purpose Of Calculating Loss Per Shares Schedule of issuance of common shares for purpose of calculating loss per shares. Segment, Reconciliation of Other Items from Segments to Consolidated [Table Text Block] Summary of Evaluating the Company's Performance and Making Key Decisions Regarding Resource Allocation Schedule Of Significant Expense Categories Regularly Reviewed By The Codm [Table Text Block] Summary of expense categories regularly reviewed by the CODM Schedule of significant expense categories regularly reviewed by the codm. Fair Value Measurements, Recurring and Nonrecurring [Table Text Block] Summary of fair value hierarchy of the valuation techniques Public Shares [Member] Public Shares [Member] IPO [Member] IPO [Member] Private Placement [Member] Private Placement [Member] Statistical Measurement [Axis] Statistical Measurement [Domain] Maximum [Member] Maximum [Member] Minimum [Member] Minimum [Member] Related Party Transaction [Axis] Related Party Transaction [Domain] Sponsor [Member] Sponsor [Member] Working Capital Loan [Member] Working Capital Loan [Member] Long-Term Debt, Type [Axis] Long-Term Debt, Type [Domain] Promissory Note [Member] Promissory Note [Member] Shares Issued, Price Per Share shares issued, price per share Shares issued, price per share Deferred Underwriting Commissions Deferred underwriting commissions Deferred underwriting commissions. Payments for Underwriting Expense Payments for underwriting expense Percentage of fair market value of target business to asset held in trust account. Percentage of fair market value of target business to asset held in trust account. Percentage of fair market value of target business to asset held in trust account. Business Combination, Voting Equity Interest Acquired, Percentage Business combination, voting equity interest acquired, percentage Share Price Share price Business days for redemption of public shares. Business days for redemption of public shares. Business days for redemption of public shares. Percentage of redeeming shares of public shares without the companys prior written consent. Percentage of redeeming shares of public shares without the company's prior written consent. Percentage of redeeming shares of public shares without the company's prior written consent. Percentage of public shares to be redeemed on noncompletion of business combination Percentage of public shares to be redeemed on non-completion of business combination Percentage of public shares to be redeemed on non-completion of business combination. Lock in period for redemption of public shares after closing of IPO. Lock in period for redemption of public shares after closing of IPO. Lock in period for redemption of public shares after closing of IPO. Dissolution Expense Dissolution expense Dissolution expense. Minimum Share Price Of The Residual Assets Remaining Available For Distribution Minimum share price of the residual assets remaining available for distribution Minimum share price of the residual assets remaining available for distribution. Proceeds from Unsecured Notes Payable Proceeds from unsecured notes payable Working Capital Deficit Working capital deficit Working capital deficit. Debt Instrument, Convertible, Carrying Amount of Equity Component Debt instrument, convertible, carrying amount of equity component Debt Instrument, Convertible, Conversion Price Debt instrument, convertible, conversion price Working Capital Loans Working capital loans Working capital loans. Other Offering Expense Other offering expense Other offering costs. Sale of Stock, Price Per Share Sale of Stock, Price Per Share Entity Incorporation, Date of Incorporation Entity Incorporation, Date of Incorporation Proceeds from Issuance of Preferred Stock and Preference Stock Proceeds from Issuance of Preferred Stock and Preference Stock Preferred Stock, Shares Subscribed but Unissued Preferred Stock, Shares Subscribed but Unissued Business Combination, Consideration Transferred Payments to Acquire Businesses, Gross Amount For Investment In Company Amount for investment in company. Amount Of Committed Private Financing Amount of committed private financing Amount of committed private financing. Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event [Member] Subsequent Event [Member] Business Combination [Axis] Business Combination [Domain] Outstanding Voting Securities [Member] Basis of Presentation and Summary of Significant Accounting Policies [Table] Basis of Presentation and Summary of Significant Accounting Policies [Line Items] Cash, FDIC Insured Amount Cash, FDIC insured amount Marketable Securities Marketable securities Percentage Of Ultimate Tax Settlement Percentage of ultimate tax settlement Percentage of ultimate tax settlement. Income Tax Examination, Penalties and Interest Expense Income tax examination, penalties and interest expense Debt Securities, Available-for-Sale Debt securities, available-for-sale Marketable securities held in Trust Account Total assets Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities Financial Instrument [Axis] Financial Instruments [Domain] US Treasury and Government [Member] Earnings Per Share, Basic, by Common Class, Including Two-Class Method [Table] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Earnings Per Share, Basic [Abstract] Basic net income (loss) per Numerator [Abstract] Denominator [Abstract] Income (Loss) from Continuing Operations, Per Basic Share Basic net income (loss) per ordinary share Temporary Equity Disclosure [Abstract] Temporary Equity, by Class of Stock [Table] Temporary Equity [Line Items] Temporary Equity, Stock Issued During Period, Value, New Issues Gross proceeds Temporary Equity Stock Issuance Costs Public Shares issuance costs Temporary Equity Stock Issuance Costs. Subsidiary or Equity Method Investee, Sale of Stock, Type [Table] Subsidiary, Sale of Stock [Line Items] Accrued Clinical Accrued clinical Accrued Clinical. Accrued Bonus Accrued bonus Accrued Bonus. Accrued Legal Accrued legal Accrued Legal. Other Accrued Liabilities, Current Accrued other Accrued Consulting Accrued consulting Accrued Consulting. Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount UK statutory income tax rate - Values Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount Change in valuation allowances - Values Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount Nondeductible transaction costs - Values Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent UK statutory income tax rate - Percent Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Change in valuation allowances - Percent Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent Nondeductible transaction costs - Percent Effective Income Tax Rate Reconciliation, Percent Effective tax rate - Percent Components of Deferred Tax Assets [Abstract] Deferred tax assets: Deferred Tax Assets, Operating Loss Carryforwards Net operating losses Deferred Tax Asset, In-Process Research and Development IPR&D capitalized expenses Deferred Tax Assets, Other Other Deferred Tax Assets, Gross Total deferred tax assets Deferred Tax Assets, Valuation Allowance Valuation allowance Deferred Tax Assets, Net of Valuation Allowance Total deferred tax assets, net of valuation allowance Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Deferred Tax Assets, Operating Loss Carryforwards, Domestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic Related and Nonrelated Parties [Axis] Related and Nonrelated Parties [Domain] Each Independent Director [Member] Each independent director. Independent Directors [Member] Independent directors. Fran Adams [Member] Founder Shares [Member] Founder shares. Ownership Percentage Threshold to Initial Shareholders Ownership percentage threshold to initial shareholders Ownership percentage threshold to initial shareholders. Shares Transfer Restrictions Description Shares transfer restrictions description Shares transfer restrictions description. Closing Price Of Shares, Transfer Restriction, Threshold Closing price of shares, transfer restriction, threshold Closing price of shares transfer restriction threshold. Fair Value Of Founder Shares Fair value of founder shares Fair value of founder shares. Fair Value Of Founder Shares Per Share Fair value of founder shares per share Fair value of founder shares per share. Implied Share Price Used In Valuation Implied share price used in valuation Implied share price used in valuation. Probability Of Business Combination Probability of business combination Probability of business combination. Share-Based Payment Arrangement, Noncash Expense Share-based payment arrangement, noncash expense Proceeds from Issuance of Debt Proceeds from issuance of debt Repayments of Debt Repayments of debt Fees for Accounting Services, Per hour Fees for accounting services, per hour Fees for accounting services, per hour. Line of Credit Facility, Maximum Borrowing Capacity Line of credit facility, maximum borrowing capacity Convertible Debt Convertible debt Share Capitalization Share capitalization Share capitalization. Trust Account Redemptions Description Trust account redemptions description Trust account redemptions description. Debt Instrument, Fee Amount Debt instrument, fee amount Amount Of Outstanding Payables To Parent Amount of outstanding payables to parent Amount of outstanding payables to parent. Debt Outstanding Debt outstanding Loan amount outstanding during the financial period. Valuation Approach and Technique [Axis] Valuation Approach and Technique [Domain] ProbabilityWeighted Expected Return Method [Member] Debt Instrument [Axis] Debt Instrument, Name [Domain] Promissory Notes [Member] Working Capital Loans [Member] Consulting Agreement [Member] Due To Related Party Balance Beginning balance Ending balance Due to related party balance. Schedule Of Allocations Are Reflected In Statements Of Operations [Table] Schedule Of Allocations Are Reflected In Statements Of Operations [Line Items] Other Research and Development Expense Research and development costs Other research and development costs Subsidiary of Common Parent [Member] Commitments and Contingencies [Table] Loss Contingency Nature [Axis] Loss Contingency, Nature [Domain] Underwriting Agreement [Member] Underwriting agreement. Commitments and Contingencies [Line Items] Underwriting Discount per share Underwriting discount per share Underwriting discount per share. Underwriting Discount Underwriting discount Underwriting discount. Deferred Underwriting Commission Per Share Deferred underwriting commission per share Deferred underwriting commission per share. Deferred Underwriting Commission Deferred underwriting commission Deferred underwriting commission. Upfront License Fee Upfront License Fee Upfront license fee. Payment Of Development Fee Upfront license fee. Payment Of Annual Net Sales Targets Payment of annual net sales targets. Percentage Of Royalty Country By Country Percentage Of Royalty Country By Country Percentage of royalty country by country. Conversion Of Stock, Conversion Ratio Conversion of stock, conversion ratio Conversion of stock, conversion ratio. Conversion Of Stock, Par Value per share Conversion of stock, par value per share Conversion of stock, par value per share. New OHBP Common Stock Issuable As Closing Consideration Description Common stock issuable as closing consideration description New OHBP common stock issuable as closing consideration description. Debt Instrument, Face Amount Debt instrument, face amount Debt Instrument, Interest Rate, Stated Percentage Bearing interest rate Backstop Committed Shares To Support Shareholder Redemptions Backstop committed shares Backstop committed shares to support shareholder redemptions. Backstop Subscription Price Per Share Backstop subscription price per share Backstop subscription price per share. Maximum Backstop Funding Commitment Amount Maximum backstop funding commitment amount Maximum backstop funding commitment amount. PIPE Purchase Price Per Share PIPE purchase price per share Pipe purchase price per share. Pre Funded Warrant Exercise Price Per Share Per share exercise price Pre funded warrant exercise price per share. PIPE Purchase Price Per Pre Funded Warrant Purchase price per Pre-Funded Warrant Pipe purchase price per pre funded warrant. Resale Registration Statement Filing Deadline In Days Resale registration statement filing deadline in days Resale registration statement filing deadline in days. Amount of Aggregate Licensed Assets Cap Amount of Aggregate Licensed Assets Cap Amount of aggregate licensed assets cap. Agreement [Axis] Agreement [Domain] Roche License Agreement [Member] Backstop Agreement [Member] Subscription Agreement [Member] Investor Rights Agreement [Member] OHBP SAFEs [Member] OHBP SAFEs [Member] SAFE Voting Percentage Required For appointment Of Directors Voting percentage required for appointment of directors Voting percentage required for appointment of directors. Conversion Features Description [Text Block] Conversion features description Conversion features description. Repurchase And Cancellation Of Deferred Shares Repurchase And Cancellation Of Deferred Shares Repurchase and cancellation of deferred shares. Deferred Share Purchase Price Deferred Share Purchase Price Deferred share purchase price. Number Of Shares Issued Number Of Shares Issued Number of shares issued. Total Splits Shares Issued Total Splits Shares Issued Total splits shares issued. Number Of Shares Outstanding Number Of Shares Outstanding Number of shares outstanding. Total Splits Shares Outstanding Total Splits Total splits shares outstanding. Weighted Average Number of Shares Outstanding, Diluted, Adjustment Shares outstanding for calculating EPS Subscription Arrangement [Axis] Subscription Arrangement [Domain] Schedule Of Redeemable convertible preferred stock [Table] Preferred Stock, Liquidation Preference, Value Preferred Stock, Liquidation Preference, Value Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value Preferred Stock, Convertible, Conversion Price Preferred Stock, Convertible, Conversion Price Series A Redeemable Convertible Preferred Stock [Member] Director [Member] Number of Reportable Segments Number of reportable segments Number of Operating Segments Number of Operating Segments Segment Reporting, Expense Information Used by CODM, Description Segment Reporting, Expense Information Used by CODM, Description Segments [Axis] Segments [Domain] General and Administrative Expense [Abstract] General and administrative costs Personnel General Costs Personnel costs Personnel general costs. Professional Fees Other General And Administrative Costs Other general and administrative costs Other general and administrative costs. Research and Development Expense [Abstract] Research and development costs License Cost License costs License cost. Clinical Research Expenses Clinical research Clinical research expenses. Personnel Costs Personnel costs Personnel costs. Fair Value, Recurring and Nonrecurring [Table] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Measurement Frequency [Axis] Measurement Frequency [Domain] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Marketable securities, Maturity Date Maturity Date Marketable securities, maturity date. Common Stock, Shares Subscribed but Unissued Common Stock, Shares Subscribed but Unissued Percentage of Simple Agreement For Future Equity Percentage of Simple Agreement For Future Equity Number of Shares [Member] Total Splits [Member]